Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone.

Bikle DD, Wang Y.

Curr Mol Pharmacol. 2012 Jun;5(2):135-42. Review.

PMID:
21787292
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Role of IGF-I signaling in regulating osteoclastogenesis.

Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD.

J Bone Miner Res. 2006 Sep;21(9):1350-8.

PMID:
16939393
[PubMed - indexed for MEDLINE]
3.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
[PubMed - indexed for MEDLINE]
4.

Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.

Shinoda Y, Kawaguchi H, Higashikawa A, Hirata M, Miura T, Saito T, Nakamura K, Chung UI, Ogata N.

J Cell Biochem. 2010 Mar 1;109(4):755-63. doi: 10.1002/jcb.22454.

PMID:
20058231
[PubMed - indexed for MEDLINE]
5.

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.

Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.

J Bone Miner Res. 2004 Nov;19(11):1873-81. Epub 2004 Aug 16.

PMID:
15476588
[PubMed - indexed for MEDLINE]
6.

Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.

Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.

J Bone Miner Res. 2000 Sep;15(9):1766-75.

PMID:
10976996
[PubMed - indexed for MEDLINE]
7.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

PMID:
16059637
[PubMed - indexed for MEDLINE]
8.

Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.

Wang Y, Sakata T, Elalieh HZ, Munson SJ, Burghardt A, Majumdar S, Halloran BP, Bikle DD.

J Endocrinol. 2006 May;189(2):279-87.

PMID:
16648295
[PubMed - indexed for MEDLINE]
Free Article
9.

Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts.

Akune T, Ogata N, Hoshi K, Kubota N, Terauchi Y, Tobe K, Takagi H, Azuma Y, Kadowaki T, Nakamura K, Kawaguchi H.

J Cell Biol. 2002 Oct 14;159(1):147-56. Epub 2002 Oct 14.

PMID:
12379806
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
11.

PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.

Green J, Goldberg R, Maor G.

Kidney Int. 2003 Feb;63(2):487-500.

PMID:
12631114
[PubMed - indexed for MEDLINE]
12.

Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.

Okamoto M, Murai J, Yoshikawa H, Tsumaki N.

J Bone Miner Res. 2006 Jul;21(7):1022-33.

PMID:
16813523
[PubMed - indexed for MEDLINE]
13.

Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.

Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP.

J Bone Miner Res. 2002 Sep;17(9):1570-8.

PMID:
12211426
[PubMed - indexed for MEDLINE]
14.

Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.

Locklin RM, Khosla S, Turner RT, Riggs BL.

J Cell Biochem. 2003 May 1;89(1):180-90.

PMID:
12682918
[PubMed - indexed for MEDLINE]
15.

Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.

Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.

J Cell Physiol. 2005 Jun;203(3):573-82.

PMID:
15573398
[PubMed - indexed for MEDLINE]
16.

The insulin-like growth factor system and the coupling of formation to resorption.

Hayden JM, Mohan S, Baylink DJ.

Bone. 1995 Aug;17(2 Suppl):93S-98S. Review.

PMID:
8579905
[PubMed - indexed for MEDLINE]
17.

Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Mukherjee A, Rotwein P.

Mol Cell Biol. 2012 Jan;32(2):490-500. doi: 10.1128/MCB.06361-11. Epub 2011 Nov 7.

PMID:
22064480
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.

Jilka RL, O'Brien CA, Bartell SM, Weinstein RS, Manolagas SC.

J Bone Miner Res. 2010 Nov;25(11):2427-37. doi: 10.1002/jbmr.145.

PMID:
20533302
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts.

Chihara K, Sugimoto T.

Horm Res. 1997;48 Suppl 5:45-9. Review.

PMID:
9434044
[PubMed - indexed for MEDLINE]
20.

Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro.

Shin HI, Divieti P, Sims NA, Kobayashi T, Miao D, Karaplis AC, Baron R, Bringhurst R, Kronenberg HM.

Endocrinology. 2004 Mar;145(3):1376-85. Epub 2003 Nov 14.

PMID:
14617570
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk